Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models.
about
Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In VivoPeptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerChapter two--Adenovirus strategies for tissue-specific targeting.An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes.
P2860
Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Evaluation of systemic targeti ...... tors in clinical mouse models.
@en
Evaluation of systemic targeti ...... tors in clinical mouse models.
@nl
type
label
Evaluation of systemic targeti ...... tors in clinical mouse models.
@en
Evaluation of systemic targeti ...... tors in clinical mouse models.
@nl
prefLabel
Evaluation of systemic targeti ...... tors in clinical mouse models.
@en
Evaluation of systemic targeti ...... tors in clinical mouse models.
@nl
P2093
P2860
P356
P1433
P1476
Evaluation of systemic targeti ...... tors in clinical mouse models.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2010.165
P577
2011-01-13T00:00:00Z
P5875
P6179
1038841502